新西兰药房为18,000名1型型糖尿病患者提供CGM和AID系统,尽管可能限制他们获得治疗。 Pharmac in NZ to provide 18,000 type 1 diabetes patients with CGMs and AID systems, despite potential access limitations.

新西兰保健供资机构药房将在宣传工作之后,为18 000名患有1型糖尿病的人提供连续的葡萄糖监测器和自动胰岛素交付系统。 Pharmac, New Zealand's health funding body, will provide continuous glucose monitors and automated insulin delivery systems for 18,000 individuals with type 1 diabetes, following advocacy efforts. 然而,保健工作人员严重短缺可能会限制获得保健的机会,特别是对于毛利人和太平洋岛屿人群体而言。 However, a significant healthcare workforce shortage may limit access, particularly for Māori and Pacific groups. 虽然这些技术改善了糖尿病管理和减少住院治疗,但使用这些技术的培训可能需要数年时间,有可能加剧健康差距。 While these technologies improve diabetes management and reduce hospitalizations, training for their use could take years, potentially exacerbating health disparities.